|
Parameters
|
Mean ± SD / N (%)
|
|---|
|
Gender
| |
|
Male
|
32 (91.43)
|
|
Female
|
3 (8.57)
|
|
Age, years
|
30.40 ± 8.40
|
|
Follow-up period, month
|
19.11 ± 6.51
|
|
Muscle strength (M)
|
3.26 ± 0.89
|
|
Muscle strength group
|
|
M < 4
|
17 (48.57)
|
|
M ≤ 4
|
18 (51.43)
|
|
CR1
|
1.23 ± 0.15
|
|
CR2
|
1.22 ± 0.13
|
|
Relation between CR1 and CR2
|
|
CR1 > CR2
|
20 (57.14)
|
|
CR1 ≤ CR2
|
15 (42.86)
|
|
MBR
|
1.00 ± 0.14
|
|
MBR group
|
|
> 1
|
18 (51.43)
|
|
≤ 1
|
17 (48.57)
|
|
ROM
|
73.66 ± 27.39
|
- CR contraction ratio, MBR muscle bulk ratio, ROM range of motion
- CR1 was the post-transplant CR value, while CR2 was the pre- transplant CR value
